SANOFI

Professional associations:
AESGP - Association of the European Self-Medication Industry
AFEP (French Association of Private Companies)
EBE
EFPIA - European Federation of Pharmaceutical
Industries Associations - and its specialized groups - EBE and Vaccines Europe
Europabio
Vaccines Europe

Think tanks :
AECA
Bruegel
Cercle des délégués permanents
EPC
Friends of Europe
Science Business

Consulting:
Fipra
CRA

For its 2018 update, Sanofi has decided to use a single entry principle for its registration. Thus, facts and figures include its following entities: Sanofi, Genzyme and Sanofi -Pasteur.

Jan 2018 - Dec 2018

1,125,000€

For its 2018 update, Sanofi has decided to use a single entry principle for its registration. Thus, facts and figures include its entities Sanofi, Genzyme and Sanofi -Pasteur

none

None

Yes, via events organised by Trade Associations, Think-Tanks or European institutions

/

32 meetings found. Download meetings

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

• Date	19 Mar 2024	Location	Brussels
  Subject	industrial competitiveness of pharma sector
  Cabinet	Cabinet of Commissioner Thierry Breton
  Attending	Thierry Breton (Commissioner)

• Date	17 Jan 2024	Location	Davos
  Subject	Meeting with Mr Roy Papatheodorou, SANOFI Executive Vice President and General Counsel
  Cabinet	Cabinet of Commissioner Stella Kyriakides
  Attending	Giorgios Rossides (Cabinet member) Stella Kyriakides (Commissioner)

• Date	14 Oct 2022	Location	Brussels, Belgium
  Subject	Pharmaceutical investments, implementation of the Pharma Strategy
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Eszter Batta (Cabinet member)

• Date	10 Jun 2022	Location	Videoconference
  Subject	Discussion on stragegic foresight
  Cabinet	Cabinet of Vice-President Maroš Šefčovič
  Portfolio	Energy Union
  Attending	Dimitri Lorenzani (Cabinet member)

• Date	10 Jun 2022	Location	Videoconference
  Subject	Discussion on stragegic foresight
  Cabinet	Cabinet of Vice-President Maroš Šefčovič
  Portfolio	Interinstitutional Relations and Foresight
  Attending	Dimitri Lorenzani (Cabinet member)

• Date	08 Jun 2022	Location	call
  Subject	health industrial ecosystem, HERA and green transition
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Maurits-Jan Prinz (Cabinet member)

• Date	03 Feb 2022	Location	Videoconference
  Subject	Initiatives in the health industrial ecosystem
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Maurits-Jan Prinz (Cabinet member)

• Date	26 Oct 2021	Location	Brussels
  Subject	Pharmaceutical sector – trade related issues
  Cabinet	Cabinet of Executive Vice-President Valdis Dombrovskis
  Portfolio	An Economy that Works for People
  Attending	Caroline Boeshertz (Cabinet member) Elina Melngaile (Cabinet member) Kevin Keary (Cabinet member)
  Other Lobbyists	Merck Pfizer Inc. European Federation of Pharmaceutical Industries and Associations

• Date	16 Jun 2021	Location	online
  Subject	Supply chains for medicines
  Cabinet	Cabinet of Vice-President Margaritis Schinas
  Portfolio	Promoting the European Way of Life
  Attending	Maria Luisa Llano Cardenal (Cabinet member) Margaritis Schinas (Vice-President)
  Other Lobbyists	European Patients' Forum (EPF) Medichem, S.A. European Healthcare Distribution Association Pfizer Inc. Teva Pharmaceuticals Europe BV Bureau Européen des Unions de Consommateurs European Chemical Industry Council MEDICINES FOR EUROPE The European Association of Hospital Pharmacists Leuphana Universität Lüneburg Fresenius Kabi Deutschland GmbH Phamaceutical Group of the European Union European Federation of Pharmaceutical Industries and Associations Novo Nordisk A/S

• Date	26 Mar 2021	Location	Videoconference
  Subject	Health in the industry policy update
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Eszter Batta (Cabinet member)

• Date	31 Jan 2021	Location	Videoconference
  Subject	Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements
  Cabinet	Cabinet of President Ursula von der Leyen
  Portfolio	President
  Attending	Ursula von der Leyen (President)
  Other Lobbyists	Johnson & Johnson AstraZeneca PLC Moderna Inc. CureVac AG BioNTech SE Pfizer Inc.

• Date	23 Nov 2020	Location	Brussels (WEBEX)
  Subject	Alliances
  Cabinet	Cabinet of President Ursula von der Leyen
  Portfolio	President
  Attending	Kurt Vandenberghe (Cabinet member)

• Date	16 Nov 2020	Location	Videoconference
  Subject	Pharmaceutical manufacturing in the EU
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Thierry Breton (Commissioner) Eszter Batta (Cabinet member)

• Date	13 Oct 2020	Location	Videoconference
  Subject	Pharmaceutical manufacturing in the EU
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Eszter Batta (Cabinet member) Thierry Breton (Commissioner)

• Date	25 May 2020	Location	Videoconference
  Subject	Perspectives on the fight against COVID-19
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Thierry Breton (Commissioner)

• Date	06 Apr 2020	Location	Videoconference
  Subject	Digitisation of healthcare and innovative e-health solutions.
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Thierry Breton (Commissioner)
  Other Lobbyists	European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry Siemens Healthineers AG Koninklijke Philips Byteflies

• Date	21 Feb 2018	Location	Brussels
  Subject	HTA; Supplementary Protection Certificates (SPC)
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member)
  Other Lobbyists	Novartis International AG

• Date	25 Jan 2018	Location	Brussels
  Subject	European patent protection
  Cabinet	Cabinet of Commissioner Pierre Moscovici
  Portfolio	Economic and Financial Affairs, Taxation and Customs
  Attending	Lucie Mattera (Cabinet member)
  Other Lobbyists	Novartis International AG

• Date	24 Jan 2018	Location	Brussels
  Subject	Digital Healthcare
  Cabinet	Cabinet of Commissioner Mariya Gabriel
  Portfolio	Digital Economy and Society
  Attending	Manuel Mateo-Goyet (Cabinet member)

• Date	24 Jan 2018	Location	BRUSSELS
  Subject	HTA; E-Health
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member)

• Date	10 Oct 2017	Location	Brussels
  Subject	Life Science in the EU
  Cabinet	Cabinet of First Vice-President Frans Timmermans
  Portfolio	Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights
  Attending	Bernardus Smulders (Cabinet member)

• Date	18 Apr 2016	Location	Brussels, Belgium
  Subject	Access to health care including pharmaceuticals in developing countries
  Cabinet	Cabinet of Vice-President Neven Mimica
  Portfolio	International Cooperation & Development
  Attending	Nils Behrndt (Cabinet member)

• Date	18 Apr 2016	Location	Berlaymont
  Subject	EPSC, Interinstitutional relations
  Cabinet	Cabinet of President Jean-Claude Juncker
  Portfolio	President
  Attending	Clara Martinez Alberola (Cabinet member)

• Date	17 Mar 2016	Location	Brussels
  Subject	AMR, HTA
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member)

• Date	02 Jul 2015	Location	Brussels
  Subject	vaccinations
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Paula Duarte Gaspar (Cabinet member) Vytenis Andriukaitis (Commissioner)

• Date	03 Jun 2015	Location	Brussels
  Subject	New College and Better Regulation
  DG	Communications Networks, Content and Technology
  Attending	Robert Madelin (Director-General)
  Other Lobbyists	Syngenta Crop Protection AG European Centre for Public Affairs American Chamber of Commerce to the European Union European Academy of Dermatology and Venereology CEMBUREAU - The European Cement Association Novartis International AG FoodDrinkEurope Oracle GIGAEurope aisbl Toy Industries of Europe European Chemical Industry Council RTL Group RELX The Walt Disney Company Benelux BVBA Acumen Public Affairs CEMA - European Agricultural Machinery Industry Association Cargill Jaguar Land Rover Limited Association des Constructeurs Européens d'Automobiles MERIAL spiritsEUROPE Dow Europe GmbH

• Date	03 Jun 2015	Location	Brussels
  Subject	New College and Better Regulation
  DG	Communications Networks, Content and Technology
  Attending	Robert Madelin (Director-General)
  Other Lobbyists	Jaguar Land Rover Limited Association des Constructeurs Européens d'Automobiles Dow Europe GmbH spiritsEUROPE Syngenta Crop Protection AG MERIAL European Centre for Public Affairs American Chamber of Commerce to the European Union European Academy of Dermatology and Venereology CEMBUREAU - The European Cement Association Novartis International AG FoodDrinkEurope Oracle GIGAEurope aisbl European Chemical Industry Council Toy Industries of Europe RTL Group The Walt Disney Company Benelux BVBA Acumen Public Affairs RELX CEMA - European Agricultural Machinery Industry Association Cargill

• Date	07 May 2015	Location	Brussels
  Subject	Implementation Council Conclusions on Vaccination
  Cabinet	Cabinet of Commissioner Carlos Moedas
  Portfolio	Research, Science and Innovation
  Attending	Giulia Del Brenna (Cabinet member)

• Date	27 Mar 2015	Location	Berlaymont
  Subject	How to strengthen a European coherent approach with focus on ERA development, ways to reduce the fragmented approach in Europe for evaluation the value of new medicines for improved access for the patient, and means of creating a more dynamic environment for medicine development in Europe and driving an ambitious agenda allowing the European life sciences sector to remain competetive on a global scale.
  Cabinet	Cabinet of President Jean-Claude Juncker
  Portfolio	President
  Attending	Clara Martinez Alberola (Cabinet member)

• Date	19 Mar 2015	Location	Brussels
  Subject	New Commission, Investment plan, TTIP
  Cabinet	Cabinet of Vice-President Jyrki Katainen
  Portfolio	Jobs, Growth, Investment and Competitiveness
  Attending	Juho Romakkaniemi (Cabinet member)

• Date	19 Feb 2015	Location	Berlaymont
  Subject	Exchange of views in the perspective to present of Health & Growth and to discuss ERA, medicine development and its access for the patient
  Cabinet	Cabinet of President Jean-Claude Juncker
  Portfolio	President
  Attending	Clara Martinez Alberola (Cabinet member)

• Date	21 Jan 2015	Location	Brussels Belgium
  Subject	A reflection on how Europe can move towards the development of a genuine European Research Area, benefiting from closer cooperation between the private and the academic and public sectors and better exploit the links between fundamental and translational research.
  Cabinet	Cabinet of Commissioner Elżbieta Bieńkowska
  Portfolio	Internal Market, Industry, Entrepreneurship and SMEs
  Attending	Rolf Carsten Bermig (Cabinet member)